|
GTDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13690000000688E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.28510000000504E-05 |
| Normal-vs-Stage2 |
6.153800E-04 |
| Normal-vs-Stage3 |
2.179600E-04 |
| Normal-vs-Stage4 |
1.458760E-03 |
| Stage1-vs-Stage2 |
2.358800E-01 |
| Stage1-vs-Stage3 |
7.546000E-01 |
| Stage1-vs-Stage4 |
9.772800E-01 |
| Stage2-vs-Stage3 |
3.414800E-01 |
| Stage2-vs-Stage4 |
3.045000E-01 |
| Stage3-vs-Stage4 |
8.484200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49379999999189E-05 |
| Normal-vs-AfricanAmerican |
3.123000E-01 |
| Normal-vs-Asian |
2.177400E-03 |
| Caucasian-vs-AfricanAmerican |
7.678200E-02 |
| Caucasian-vs-Asian |
8.461600E-01 |
| AfricanAmerican-vs-Asian |
1.713010E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.696100E-03 |
| Normal-vs-Female |
1.88759999999455E-05 |
| Male-vs-Female |
1.701180E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.356100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.31779999999571E-05 |
| Normal-vs-Age(61-80Yrs) |
3.351400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.126400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.114200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.436000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.290600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.759000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.428800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.458200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.336400E-01 |
| Classical-VS-Follicular |
1.493520E-02 |
| Classical-VS-Other |
9.137400E-01 |
| Classical-VS-Normal |
8.810900E-04 |
| Tall-VS-Follicular |
4.949000E-01 |
| Tall-VS-Other |
6.220200E-01 |
| Tall-VS-Normal |
1.398760E-03 |
| Follicular-VS-Other |
4.932200E-01 |
| Follicular-VS-Normal |
5.77149999999582E-05 |
| Other-VS-Normal |
1.682430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3725000000141E-06 |
| Normal-vs-N1 |
1.199030E-04 |
| N0-vs-N1 |
7.188600E-01 |
|
|
